Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price to Book Value : 9.776 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 9.847 |
| August 20, 2026 | 9.986 |
| August 19, 2026 | 9.617 |
| August 18, 2026 | 9.252 |
| August 17, 2026 | 9.341 |
| August 14, 2026 | 9.480 |
| August 13, 2026 | 9.445 |
| August 12, 2026 | 9.701 |
| August 11, 2026 | 9.411 |
| August 10, 2026 | 9.167 |
| August 07, 2026 | 9.883 |
| August 06, 2026 | 10.37 |
| August 05, 2026 | 14.01 |
| August 04, 2026 | 14.34 |
| August 03, 2026 | 14.23 |
| July 31, 2026 | 14.34 |
| July 30, 2026 | 14.66 |
| July 29, 2026 | 13.69 |
| July 28, 2026 | 13.79 |
| July 27, 2026 | 13.90 |
| July 24, 2026 | 13.25 |
| July 23, 2026 | 13.25 |
| July 22, 2026 | 13.69 |
| July 21, 2026 | 14.12 |
| July 20, 2026 | 13.90 |
| Date | Value |
|---|---|
| July 17, 2026 | 14.55 |
| July 16, 2026 | 15.21 |
| July 15, 2026 | 14.99 |
| July 14, 2026 | 15.21 |
| July 13, 2026 | 14.99 |
| July 10, 2026 | 15.21 |
| July 09, 2026 | 15.53 |
| July 08, 2026 | 15.42 |
| July 07, 2026 | 14.77 |
| July 06, 2026 | 14.12 |
| July 02, 2026 | 13.47 |
| July 01, 2026 | 13.14 |
| June 30, 2026 | 12.38 |
| June 29, 2026 | 10.86 |
| June 26, 2026 | 11.16 |
| June 25, 2026 | 10.18 |
| June 24, 2026 | 10.37 |
| June 23, 2026 | 10.77 |
| June 22, 2026 | 10.67 |
| June 18, 2026 | 10.47 |
| June 17, 2026 | 9.982 |
| June 16, 2026 | 9.63 |
| June 15, 2026 | 9.187 |
| June 12, 2026 | 9.048 |
| June 11, 2026 | 8.802 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Emergent BioSolutions, Inc. | 0.7768 |
| Exelixis, Inc. | 7.366 |
| ADMA Biologics, Inc. | 5.269 |
| Arcutis Biotherapeutics, Inc. | 14.11 |
| Relay Therapeutics, Inc. | 4.852 |
Price to Book Value Related Metrics
| PS Ratio | 1.106 |
| Price to Free Cash Flow | 6.016 |
| Price | 0.9001 |
| Earnings Yield | -12.33% |
| Market Cap | 244.60M |